Accountability for Care Through Undoing Racism & Equity for Moms
Part of paid clinical trials in Chapel Hill, North Carolina.
- Sponsor
- University of North Carolina, Chapel Hill
- Study ID
- NCT05484804
- Status
- Recruiting
Conditions
- Implicit Bias
- Low Birthweight
- Maternal Health
- Maternal Mortality
- Pregnancy Related
- Racism
Eligibility Criteria
- Sex
- FEMALE
- Age
- 12 Years - 99 Years
- Healthy Volunteers
- Accepted
Interventions
- Data Accountability and Transparency — OTHERCollaboration with Practice Facilitators; Maternal Early Warning System; Disparities Dashboard; Racial Equity Training
- Community-Based Doula (CBD) Support — OTHERCommunity-Based Doula support for high-risk patients; Racial Equity Training
Study Details
This project-also known as "Accountability for Care through Undoing Racism \& Equity for Moms" or ACURE4Moms-aims to reduce Black-White maternal health disparities using multi-level interventions designed to decrease bias in prenatal care, improve care coordination, and increase social support. ACURE4Moms is a pragmatic 4-arm cluster randomized controlled trial conducted with 39 prenatal practices across North Carolina. Practices have been randomly assigned to receive either: Arm 1 (Standard Care): North Carolina Medicaid Care management for high-risk pregnancies; Arm 2 (Data Accountability and Transparency): North Carolina Medicaid Care Management + Practice-level Data Accountability interventions; Arm 3 (Community-Based Doula Support): North Carolina Medicaid Care Management + Community-Based Doula support intervention for high-risk patients during pregnancy and postpartum; or Arm 4 (Data Accountability and Transparency + Community-Based Doula Support): North Carolina Medicaid Care Management + Both Arms 2 and 3 interventions. During each practice's 2-year intervention period, the practice will initiate prenatal care for \~750-1,500 patients (up to 60,000 patients total), whose outcomes the investigators will follow and compare between arms until all these patients have reached 1-year post-delivery.
Key Dates
- Start date
- Jun 5, 2023
- Status verified
- Apr 2026
- Primary completion
- Jul 31, 2027
- Completion
- Aug 31, 2027
Study Design
- Enrollment
- 60,000 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- FACTORIAL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- No Intervention: Standard CarePregnant patients with Medicaid insurance are screened for risk factors for low birthweight, and high-risk patients receive intensive care management.
- Active Comparator: Data Accountability and TransparencyPregnant patients with Medicaid insurance are screened for risk factors for low birthweight, and high-risk patients receive intensive care management. Additionally, practices receive 2 additional patient-level interventions, including: 1) Support from a Practice Facilitator to help implement the interventions and build workflows and quality improvement cycles; 2) Use of a Maternal Warning System for missed visits, elevated blood pressures, and prenatal aspirin eligibility; 3) Use of a Data Dashboard that displays outcome data stratified by race, ethnicity, age, and preferred language; and 4) Maternal Health Equity Education \& Training sessions.
- Active Comparator: Community-Based Doula (CBD) SupportPregnant patients with Medicaid insurance are screened for risk factors for low birthweight, and high-risk patients receive intensive care management. Additionally, practices receive 2 additional patient-level interventions, including: 1) Shared care of high-risk patients with Community-Based Doulas; and 2) Maternal Health Equity Education \& Training sessions.
- Active Comparator: Data Accountability and Transparency + Community-Based Doula SupportPregnant patients with Medicaid insurance are screened for risk factors for low birthweight, and high-risk patients receive intensive care management, and practices receive all the Data Accountability and Doula Interventions described in Arms 2 and 3.
Primary Outcome Measure
Odds of delivery of low-birthweight infants among non-Hispanic Black patients in each study arm [ Time Frame: Upon delivery ]
Central Contacts
- Jennifer H Tang, MD, MSCR919-962-4880
- Rabab S Husain, MA919-962-4880
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27599 |
Find similar trials in Chapel Hill, NC
Related Studies
- Maternal Autoimmune Disease Research Alliance (MADRA) RegistryRecruiting · Duke University · Durham, North Carolina
- Patient Centered Simulation For Labor and DeliveryNot Yet Recruiting · Wake Forest University Health Sciences · Winston-Salem, North Carolina
- Effects of Systematic Cervical Exam Training on Labor and Delivery CareRecruiting · Wake Forest University Health Sciences · Winston-Salem, North Carolina
- WAKIX® (Pitolisant) Pregnancy RegistryRecruiting · Harmony Biosciences Management, Inc. · Morrisville, North Carolina